Communities of Practice

CoP in Enhanced Recovery After Surgery (ERAS) & Venous Thromboembolism (VTE). To improve perioperative care and patient outcomes. To advance the implementation of ERAS principles and the development and dissemination of up-to-date, evidence-based recommendations for VTE prophylaxis and treatment in patients with gynecologic malignancies. To standardize care, address practice gaps, and reduce postoperative complications, morbidity, and mortality in this patient population.

CoP in BReast CAncer gene (BRCA). To advance the identification and management of hereditary cancer risk. To promote best practices in genetic testing, counselling, and risk-reducing strategies for individuals with BRCA mutations. To support consistent, evidence-based care that aims to improve early detection, prevention, and outcomes for patients at increased risk of gynecologic cancers.

CoP in Low-Grade Serous Carcinoma (LGSC) & Rare Diseases. To improve care for patients with uncommon and complex diseases. To develop standardized treatment guidelines and establish national patient registries and biobanking initiatives to advance knowledge and research. To enhance understanding, support evidence-based care, and improve outcomes for patients with rare gynecologic cancers.

Newly being developed

CoP in Quality Improvement and Patient Safety (QIPS). To develop evidence-based recommendations, standards and knowledge translation initiatives on topics that impact the daily practice of gynecologic oncology. To maintain a multi-institution database to enable shared research projects and QI initiatives. To facilitate collaborations between centres that are members of the National Surgical Quality Improvement Program (NSQIP). To support QI education and teaching for fellows and residents with a focus on gynecologic oncology.

CoP in Human papillomavirus (HPV)-Related Diseases. To provide a dynamic and evolving platform for collaboration, knowledge exchange, and the development of best practices in HPV and HPV-associated cancers, particularly cervical cancer. To advance prevention, screening, and management strategies to improve outcomes in HPV-related gynecologic cancers.

CoP in Gestational Trophoblastic Disease (GTD)-Gestational Trophoblastic Neoplasia (GTN). To identify national priorities for GTN care, develop standardized care pathways, and build a coordinated network supported by a national database. To create accessible patient information tools, to improve consistency of care, advance research, and enhance outcomes for patients affected by GTD and GTN.